FDA OKs Amvuttra to Treat Heart Conditions
Kennedy Orders Takedown of Fake CDC Vaccine Web Page
FDA Approves Tremfya for Active Crohn Disease in Adults
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease
Low-Dose Doxycycline Effective for Lymphocytic Scarring Alopecias
Effectiveness with low-dose doxycycline as effective as with high doses, but with greater tolerability
ACP Issues Clinical Guideline for Pharmacologic Treatment of Acute Episodic Migraine
ACP recommends adding triptan to NSAID or acetaminophen to treat moderate-to-severe acute episodic migraine
Microplastics Found in Filtered Solutions Used for Medical IV Infusions
Microplastic particles ranged in size from 1 to 62 µm, with about 90 percent ranging from 1 to 20 µm
Ensitrelvir Effectively Prevents Spread of COVID-19 in Households
In recent study, 9 percent of participants taking placebo developed COVID-19 versus 2.9 percent of people taking ensitrelvir
FDA Announces ‘Operation Stork Speed’ to Improve Infant Formula
Program will enhance the nutrient review process, increase testing for contaminants, encourage companies to develop new formulas
Tirzepatide, Semaglutide Not Cost-Effective at Current Prices
Tirzepatide and semaglutide offer long-term health benefits, but would require discounts to reach $100,000/QALY threshold
Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease
Improved Fibrosis-4 group transitions seen over time for patients with chronic liver disease using statins
